Bipolar androgen therapy in castration-resistant prostate cancer: Biological rationale, clinical evidence, and future directions.
- DOI
- 10.1097/cu9.0000000000000374
- Published
- 2026 Nov
- Container
- Current urology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1097/cu9.0000000000000374,
title = {Bipolar androgen therapy in castration-resistant prostate cancer: Biological rationale, clinical evidence, and future directions.},
author = {Rival PM and Jiang J and Qu LG and O'Brien J and Gilmore P and Corcoran N},
year = {2026},
journal = {Current urology},
doi = {10.1097/cu9.0000000000000374},
url = {https://doi.org/10.1097/cu9.0000000000000374}
}RIS
TY - JOUR TI - Bipolar androgen therapy in castration-resistant prostate cancer: Biological rationale, clinical evidence, and future directions. AU - Rival PM AU - Jiang J AU - Qu LG AU - O'Brien J AU - Gilmore P AU - Corcoran N PY - 2026 JO - Current urology DO - 10.1097/cu9.0000000000000374 UR - https://doi.org/10.1097/cu9.0000000000000374 ER -
APA
PM, R., J, J., LG, Q., J, O., P, G., & N, C. (2026). Bipolar androgen therapy in castration-resistant prostate cancer: Biological rationale, clinical evidence, and future directions.. Current urology. https://doi.org/10.1097/cu9.0000000000000374
Source records
- pubmed · retrieved 2026-11-10T19:09:45.706Z